Tajiri

Shenzhen, China · Founded 2014 · Privately Held (backing)

Developer of anti-cancer medical solutions intended to address drug resistance and urgent clinical needs through next-generation small-molecule therapies. Tajiri is based in Shenzhen, China and was founded in 2014. Its last reported valuation was $146 million in Apr 2020. It has raised $85.8 million.

Last reported valuation
$145.6M
Oct 2026
Priced at
—
Total raised
$85.8M
Last round
—

Who backs Tajiri?

12 investors
InvestorType
Shenzhen Capital GroupVenture capital
Oriental Fortune CapitalVenture capital
CDH InvestmentsPE / buyout
SEEDS CapitalVenture capital
Hongtai Capital HoldingsVenture capital
WinPowerOther
CDH Shanghai Dinghui Bai Fu Wealth Management—
Shanghai Zhurui Equity Investment Management—
Shenzhen Lihe Angel Phase II Investment Management—
Tibet Linzhi Dingfu Capital Management—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Tajiri investors

12 investors are on record for Tajiri, including Shenzhen Capital Group, Oriental Fortune Capital, CDH Investments and SEEDS Capital. By type, the record holds 4 venture capital firms and 1 private equity firm.

Free account
More of Tajiri with a free account
  • ·The complete investor list: 12 names
  • ·Watch Tajiri: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Tajiri. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View